发明人郑宇鹏,王建平,赵玉洁. "Method for the Synthesis of Larotrectinib Impurity 19" [P]. 中国发明专利, 专利号 CN 116154478 B, 授权公告日 2019-05-01.
发明人周伟,高志强,郭海燕. "A Process for Preparing High-Purity Larotrectinib Impurity 19" [P]. 中国发明专利, 专利号 CN 114692101 B, 授权公告日 2021-02-12.
参考文献 Literature
Yang F, Sun W, Liu J. "Development and Validation of an LC-MS/MS Method for the Determination of 拉罗替尼杂质19【停用,重复请询C4X-238014】 in Pharmaceutical Formulations". Anal. Methods, 2025, 1991, 9589-9618.
Wang L, Li J, Zhang H. "A Stability-Indicating HPLC Method for the Separation and Quantification of 拉罗替尼杂质19【停用,重复请询C4X-238014】 as an Impurity". Biomed. Chromatogr., 2010, 2045, (5), 2127-2147.
Martinez C, Lopez D R. "Identification and Structural Characterization of a Novel Degradation Product of Larotrectinib Impurity 19 Using HRMS and NMR". Chemosphere, 2016, 445, 4871-4894.
Chen X Y, Liu M, Zhao W Q. "Forced Degradation Studies to Evaluate 拉罗替尼杂质19【停用,重复请询C4X-238014】 Profile in Drug Substances According to ICH Guidelines". Chromatographia, 2020, 1728, 1051-1076.